Listed

Trevi Therapeutics, Inc.

TRVINasdaqCIK 1563880HealthcareFiscal year ends Dec 31

Share

Share this page

Story card, 1080 × 1920

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Operating income−$20.5m, Q2 FY2026
Net income−$17.8m, Q2 FY2026
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Research and development$m6.3Research and development, Q3 FY2023, three months to 2023-09-30$6.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-11-06, accession 0000950170-24-122355.Report this figure6.5Research and development, Q4 FY2023, three months to 2023-12-31$6.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2025-03-18, accession 0000950170-25-041194. Derived: 12-month figure less the 9-month figure.Report this figure8.8Research and development, Q1 FY2024, three months to 2024-03-31$8.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-08, accession 0000950170-25-067011.Report this figure10.0Research and development, Q2 FY2024, three months to 2024-06-30$10.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-07, accession 0000950170-25-105066.Report this figure11.2Research and development, Q3 FY2024, three months to 2024-09-30$11.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-13, accession 0001193125-25-280166.Report this figure9.3Research and development, Q4 FY2024, three months to 2024-12-31$9.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-17, accession 0001193125-26-110783. Derived: 12-month figure less the 9-month figure.Report this figure7.8Research and development, Q1 FY2025, three months to 2025-03-31$7.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-05, accession 0001193125-26-206390.Report this figure9.4Research and development, Q2 FY2025, three months to 2025-06-30$9.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-06, accession 0001193125-26-338023.Report this figure10.1Research and development, Q3 FY2025, three months to 2025-09-30$10.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-13, accession 0001193125-25-280166.Report this figure6.2Research and development, Q4 FY2025, three months to 2025-12-31$6.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-17, accession 0001193125-26-110783. Derived: 12-month figure less the 9-month figure.Report this figure9.9Research and development, Q1 FY2026, three months to 2026-03-31$9.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-05, accession 0001193125-26-206390.Report this figure15.2Research and development, Q2 FY2026, three months to 2026-06-30$15.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-06, accession 0001193125-26-338023.Report this figure
Operating income$m(9.0)Operating income, Q3 FY2023, three months to 2023-09-30−$9.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-06, accession 0000950170-24-122355.Report this figure(8.9)Operating income, Q4 FY2023, three months to 2023-12-31−$8.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-03-18, accession 0000950170-25-041194. Derived: 12-month figure less the 9-month figure.Report this figure(11.9)Operating income, Q1 FY2024, three months to 2024-03-31−$11.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-08, accession 0000950170-25-067011.Report this figure(13.3)Operating income, Q2 FY2024, three months to 2024-06-30−$13.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-07, accession 0000950170-25-105066.Report this figure(14.1)Operating income, Q3 FY2024, three months to 2024-09-30−$14.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-13, accession 0001193125-25-280166.Report this figure(12.2)Operating income, Q4 FY2024, three months to 2024-12-31−$12.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-17, accession 0001193125-26-110783. Derived: 12-month figure less the 9-month figure.Report this figure(11.5)Operating income, Q1 FY2025, three months to 2025-03-31−$11.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-05, accession 0001193125-26-206390.Report this figure(13.7)Operating income, Q2 FY2025, three months to 2025-06-30−$13.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-06, accession 0001193125-26-338023.Report this figure(13.9)Operating income, Q3 FY2025, three months to 2025-09-30−$13.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-13, accession 0001193125-25-280166.Report this figure(10.2)Operating income, Q4 FY2025, three months to 2025-12-31−$10.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-17, accession 0001193125-26-110783. Derived: 12-month figure less the 9-month figure.Report this figure(14.9)Operating income, Q1 FY2026, three months to 2026-03-31−$14.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-05, accession 0001193125-26-206390.Report this figure(20.5)Operating income, Q2 FY2026, three months to 2026-06-30−$20.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-06, accession 0001193125-26-338023.Report this figure
Interest expense$m0.0Interest expense, Q3 FY2023, three months to 2023-09-30$3.0k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2023-11-09, accession 0000950170-23-062063.Report this figure0.0Interest expense, Q4 FY2023, three months to 2023-12-31$4.0k. XBRL concept us-gaap:InterestExpense. 10-K filed 2024-03-20, accession 0000950170-24-034167. Derived: 12-month figure less the 9-month figure.Report this figure0.0Interest expense, Q1 FY2024, three months to 2024-03-31$1.0k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2024-05-07, accession 0000950170-24-054489.Report this figure0.0Interest expense, Q2 FY2024, three months to 2024-06-30$1.0k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2024-08-08, accession 0000950170-24-093983.Report this figure0.0Interest expense, Q3 FY2024, three months to 2024-09-30$1.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-11-13, accession 0001193125-25-280166.Report this figure0.0Interest expense, Q4 FY2024, three months to 2024-12-31$1.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-K filed 2026-03-17, accession 0001193125-26-110783. Derived: 12-month figure less the 9-month figure.Report this figurenot reported0.0Interest expense, Q2 FY2025, three months to 2025-06-30$0. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-08-07, accession 0000950170-25-105066.Report this figure0.0Interest expense, Q3 FY2025, three months to 2025-09-30$0. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-11-13, accession 0001193125-25-280166.Report this figure0.0Interest expense, Q4 FY2025, three months to 2025-12-31$0. XBRL concept us-gaap:InterestExpenseNonoperating. 10-K filed 2026-03-17, accession 0001193125-26-110783. Derived: 12-month figure less the 9-month figure.Report this figurenot reportednot reported
Income tax$m(0.0)Income tax, Q3 FY2023, three months to 2023-09-30−$13.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2024-11-06, accession 0000950170-24-122355.Report this figure0.0Income tax, Q4 FY2023, three months to 2023-12-31$18.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2025-03-18, accession 0000950170-25-041194. Derived: 12-month figure less the 9-month figure.Report this figure(0.0)Income tax, Q1 FY2024, three months to 2024-03-31−$8.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-05-08, accession 0000950170-25-067011.Report this figure(0.0)Income tax, Q2 FY2024, three months to 2024-06-30−$8.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-08-07, accession 0000950170-25-105066.Report this figure(0.0)Income tax, Q3 FY2024, three months to 2024-09-30−$31.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-13, accession 0001193125-25-280166.Report this figure0.0Income tax, Q4 FY2024, three months to 2024-12-31$16.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-03-17, accession 0001193125-26-110783. Derived: 12-month figure less the 9-month figure.Report this figure(0.0)Income tax, Q1 FY2025, three months to 2025-03-31−$11.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-05, accession 0001193125-26-206390.Report this figure(0.0)Income tax, Q2 FY2025, three months to 2025-06-30−$21.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-06, accession 0001193125-26-338023.Report this figure(0.0)Income tax, Q3 FY2025, three months to 2025-09-30−$15.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-13, accession 0001193125-25-280166.Report this figure(0.0)Income tax, Q4 FY2025, three months to 2025-12-31−$16.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-03-17, accession 0001193125-26-110783. Derived: 12-month figure less the 9-month figure.Report this figure(0.0)Income tax, Q1 FY2026, three months to 2026-03-31−$20.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-05, accession 0001193125-26-206390.Report this figure(0.0)Income tax, Q2 FY2026, three months to 2026-06-30−$19.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-06, accession 0001193125-26-338023.Report this figure
Net income$m(7.7)Net income, Q3 FY2023, three months to 2023-09-30−$7.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-06, accession 0000950170-24-122355.Report this figure(7.8)Net income, Q4 FY2023, three months to 2023-12-31−$7.8m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-03-18, accession 0000950170-25-041194. Derived: 12-month figure less the 9-month figure.Report this figure(10.9)Net income, Q1 FY2024, three months to 2024-03-31−$10.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-05-08, accession 0000950170-25-067011.Report this figure(12.4)Net income, Q2 FY2024, three months to 2024-06-30−$12.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-08-07, accession 0000950170-25-105066.Report this figure(13.2)Net income, Q3 FY2024, three months to 2024-09-30−$13.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-13, accession 0001193125-25-280166.Report this figure(11.4)Net income, Q4 FY2024, three months to 2024-12-31−$11.4m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-17, accession 0001193125-26-110783. Derived: 12-month figure less the 9-month figure.Report this figure(10.3)Net income, Q1 FY2025, three months to 2025-03-31−$10.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-05, accession 0001193125-26-206390.Report this figure(12.3)Net income, Q2 FY2025, three months to 2025-06-30−$12.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-06, accession 0001193125-26-338023.Report this figure(11.8)Net income, Q3 FY2025, three months to 2025-09-30−$11.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-13, accession 0001193125-25-280166.Report this figure(8.3)Net income, Q4 FY2025, three months to 2025-12-31−$8.3m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-17, accession 0001193125-26-110783. Derived: 12-month figure less the 9-month figure.Report this figure(13.2)Net income, Q1 FY2026, three months to 2026-03-31−$13.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-05, accession 0001193125-26-206390.Report this figure(17.8)Net income, Q2 FY2026, three months to 2026-06-30−$17.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-06, accession 0001193125-26-338023.Report this figure
Diluted EPS$ per share(0.08)Diluted EPS, Q3 FY2023, three months to 2023-09-30−$0.08 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-06, accession 0000950170-24-122355.Report this figurenot reported(0.11)Diluted EPS, Q1 FY2024, three months to 2024-03-31−$0.11 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-08, accession 0000950170-25-067011.Report this figure(0.12)Diluted EPS, Q2 FY2024, three months to 2024-06-30−$0.12 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-07, accession 0000950170-25-105066.Report this figure(0.13)Diluted EPS, Q3 FY2024, three months to 2024-09-30−$0.13 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-13, accession 0001193125-25-280166.Report this figurenot reported(0.09)Diluted EPS, Q1 FY2025, three months to 2025-03-31−$0.09 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-05, accession 0001193125-26-206390.Report this figure(0.09)Diluted EPS, Q2 FY2025, three months to 2025-06-30−$0.09 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-06, accession 0001193125-26-338023.Report this figure(0.08)Diluted EPS, Q3 FY2025, three months to 2025-09-30−$0.08 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-13, accession 0001193125-25-280166.Report this figurenot reported(0.09)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$0.09 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-05, accession 0001193125-26-206390.Report this figure(0.11)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$0.11 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-06, accession 0001193125-26-338023.Report this figure
Basic EPS$ per share(0.08)Basic EPS, Q3 FY2023, three months to 2023-09-30−$0.08 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-06, accession 0000950170-24-122355.Report this figurenot reported(0.11)Basic EPS, Q1 FY2024, three months to 2024-03-31−$0.11 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-08, accession 0000950170-25-067011.Report this figure(0.12)Basic EPS, Q2 FY2024, three months to 2024-06-30−$0.12 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-07, accession 0000950170-25-105066.Report this figure(0.13)Basic EPS, Q3 FY2024, three months to 2024-09-30−$0.13 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-13, accession 0001193125-25-280166.Report this figurenot reported(0.09)Basic EPS, Q1 FY2025, three months to 2025-03-31−$0.09 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-05, accession 0001193125-26-206390.Report this figure(0.09)Basic EPS, Q2 FY2025, three months to 2025-06-30−$0.09 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-06, accession 0001193125-26-338023.Report this figure(0.08)Basic EPS, Q3 FY2025, three months to 2025-09-30−$0.08 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-13, accession 0001193125-25-280166.Report this figurenot reported(0.09)Basic EPS, Q1 FY2026, three months to 2026-03-31−$0.09 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-05, accession 0001193125-26-206390.Report this figure(0.11)Basic EPS, Q2 FY2026, three months to 2026-06-30−$0.11 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-06, accession 0001193125-26-338023.Report this figure

Balance sheet

Cash and equivalents$54.3m, Q2 FY2026
Shareholders' equity$321.5m, Q2 FY2026
Line itemUnitQ3 FY20232023-09-30FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$m26.0Cash and equivalents, Q3 FY2023, at 2023-09-30$26.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2023-11-09, accession 0000950170-23-062063.Report this figure32.4Cash and equivalents, FY2023, at 2023-12-31$32.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-03-18, accession 0000950170-25-041194.Report this figure13.8Cash and equivalents, Q1 FY2024, at 2024-03-31$13.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-05-07, accession 0000950170-24-054489.Report this figure13.0Cash and equivalents, Q2 FY2024, at 2024-06-30$13.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-08-08, accession 0000950170-24-093983.Report this figure16.1Cash and equivalents, Q3 FY2024, at 2024-09-30$16.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-06, accession 0000950170-24-122355.Report this figure34.1Cash and equivalents, FY2024, at 2024-12-31$34.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-03-17, accession 0001193125-26-110783.Report this figure19.4Cash and equivalents, Q1 FY2025, at 2025-03-31$19.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-08, accession 0000950170-25-067011.Report this figure117Cash and equivalents, Q2 FY2025, at 2025-06-30$117.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-07, accession 0000950170-25-105066.Report this figure56.9Cash and equivalents, Q3 FY2025, at 2025-09-30$56.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-13, accession 0001193125-25-280166.Report this figure18.9Cash and equivalents, FY2025, at 2025-12-31$18.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-06, accession 0001193125-26-338023.Report this figure19.4Cash and equivalents, Q1 FY2026, at 2026-03-31$19.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-05, accession 0001193125-26-206390.Report this figure54.3Cash and equivalents, Q2 FY2026, at 2026-06-30$54.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-06, accession 0001193125-26-338023.Report this figure
Current assets$m94.0Current assets, Q3 FY2023, at 2023-09-30$94.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-11-09, accession 0000950170-23-062063.Report this figure87.5Current assets, FY2023, at 2023-12-31$87.5m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-03-18, accession 0000950170-25-041194.Report this figure76.8Current assets, Q1 FY2024, at 2024-03-31$76.8m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-07, accession 0000950170-24-054489.Report this figure72.1Current assets, Q2 FY2024, at 2024-06-30$72.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-08, accession 0000950170-24-093983.Report this figure67.3Current assets, Q3 FY2024, at 2024-09-30$67.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-06, accession 0000950170-24-122355.Report this figure109Current assets, FY2024, at 2024-12-31$109.4m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-03-17, accession 0001193125-26-110783.Report this figure106Current assets, Q1 FY2025, at 2025-03-31$105.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-08, accession 0000950170-25-067011.Report this figure207Current assets, Q2 FY2025, at 2025-06-30$207.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-07, accession 0000950170-25-105066.Report this figure198Current assets, Q3 FY2025, at 2025-09-30$198.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-13, accession 0001193125-25-280166.Report this figure192Current assets, FY2025, at 2025-12-31$191.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-06, accession 0001193125-26-338023.Report this figure176Current assets, Q1 FY2026, at 2026-03-31$176.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-05, accession 0001193125-26-206390.Report this figure326Current assets, Q2 FY2026, at 2026-06-30$325.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-06, accession 0001193125-26-338023.Report this figure
Total assets$m95.9Total assets, Q3 FY2023, at 2023-09-30$95.9m. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-09, accession 0000950170-23-062063.Report this figure89.4Total assets, FY2023, at 2023-12-31$89.4m. XBRL concept us-gaap:Assets. 10-K filed 2025-03-18, accession 0000950170-25-041194.Report this figure78.6Total assets, Q1 FY2024, at 2024-03-31$78.6m. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-07, accession 0000950170-24-054489.Report this figure73.8Total assets, Q2 FY2024, at 2024-06-30$73.8m. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-08, accession 0000950170-24-093983.Report this figure68.9Total assets, Q3 FY2024, at 2024-09-30$68.9m. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-06, accession 0000950170-24-122355.Report this figure111Total assets, FY2024, at 2024-12-31$110.9m. XBRL concept us-gaap:Assets. 10-K filed 2026-03-17, accession 0001193125-26-110783.Report this figure107Total assets, Q1 FY2025, at 2025-03-31$107.0m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-08, accession 0000950170-25-067011.Report this figure208Total assets, Q2 FY2025, at 2025-06-30$208.3m. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-07, accession 0000950170-25-105066.Report this figure199Total assets, Q3 FY2025, at 2025-09-30$199.4m. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-13, accession 0001193125-25-280166.Report this figure193Total assets, FY2025, at 2025-12-31$193.4m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-06, accession 0001193125-26-338023.Report this figure180Total assets, Q1 FY2026, at 2026-03-31$179.6m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-05, accession 0001193125-26-206390.Report this figure331Total assets, Q2 FY2026, at 2026-06-30$330.5m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-06, accession 0001193125-26-338023.Report this figure
Current liabilities$m5.2Current liabilities, Q3 FY2023, at 2023-09-30$5.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-11-09, accession 0000950170-23-062063.Report this figure5.8Current liabilities, FY2023, at 2023-12-31$5.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-03-18, accession 0000950170-25-041194.Report this figure5.3Current liabilities, Q1 FY2024, at 2024-03-31$5.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-07, accession 0000950170-24-054489.Report this figure6.8Current liabilities, Q2 FY2024, at 2024-06-30$6.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-08, accession 0000950170-24-093983.Report this figure9.1Current liabilities, Q3 FY2024, at 2024-09-30$9.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-06, accession 0000950170-24-122355.Report this figure10.5Current liabilities, FY2024, at 2024-12-31$10.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-03-17, accession 0001193125-26-110783.Report this figure6.9Current liabilities, Q1 FY2025, at 2025-03-31$6.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-08, accession 0000950170-25-067011.Report this figure9.2Current liabilities, Q2 FY2025, at 2025-06-30$9.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-07, accession 0000950170-25-105066.Report this figure9.0Current liabilities, Q3 FY2025, at 2025-09-30$9.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-13, accession 0001193125-25-280166.Report this figure9.7Current liabilities, FY2025, at 2025-12-31$9.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-06, accession 0001193125-26-338023.Report this figure7.1Current liabilities, Q1 FY2026, at 2026-03-31$7.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-05, accession 0001193125-26-206390.Report this figure8.7Current liabilities, Q2 FY2026, at 2026-06-30$8.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-06, accession 0001193125-26-338023.Report this figure
Total liabilities$m6.3Total liabilities, Q3 FY2023, at 2023-09-30$6.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-11-09, accession 0000950170-23-062063.Report this figure6.9Total liabilities, FY2023, at 2023-12-31$6.9m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-03-18, accession 0000950170-25-041194.Report this figure6.2Total liabilities, Q1 FY2024, at 2024-03-31$6.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-07, accession 0000950170-24-054489.Report this figure7.6Total liabilities, Q2 FY2024, at 2024-06-30$7.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-08, accession 0000950170-24-093983.Report this figure9.9Total liabilities, Q3 FY2024, at 2024-09-30$9.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-06, accession 0000950170-24-122355.Report this figure11.3Total liabilities, FY2024, at 2024-12-31$11.3m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-03-17, accession 0001193125-26-110783.Report this figure7.5Total liabilities, Q1 FY2025, at 2025-03-31$7.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-08, accession 0000950170-25-067011.Report this figure9.8Total liabilities, Q2 FY2025, at 2025-06-30$9.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-07, accession 0000950170-25-105066.Report this figure9.6Total liabilities, Q3 FY2025, at 2025-09-30$9.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-13, accession 0001193125-25-280166.Report this figure10.2Total liabilities, FY2025, at 2025-12-31$10.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-06, accession 0001193125-26-338023.Report this figure7.5Total liabilities, Q1 FY2026, at 2026-03-31$7.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-05, accession 0001193125-26-206390.Report this figure9.0Total liabilities, Q2 FY2026, at 2026-06-30$9.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-06, accession 0001193125-26-338023.Report this figure
Shareholders' equity$m89.6Shareholders' equity, Q3 FY2023, at 2023-09-30$89.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-06, accession 0000950170-24-122355.Report this figure82.5Shareholders' equity, FY2023, at 2023-12-31$82.5m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-03-17, accession 0001193125-26-110783.Report this figure72.3Shareholders' equity, Q1 FY2024, at 2024-03-31$72.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-08-07, accession 0000950170-25-105066.Report this figure66.2Shareholders' equity, Q2 FY2024, at 2024-06-30$66.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-13, accession 0001193125-25-280166.Report this figure59.0Shareholders' equity, Q3 FY2024, at 2024-09-30$59.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-13, accession 0001193125-25-280166.Report this figure99.6Shareholders' equity, FY2024, at 2024-12-31$99.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001193125-26-338023.Report this figure99.5Shareholders' equity, Q1 FY2025, at 2025-03-31$99.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001193125-26-338023.Report this figure198Shareholders' equity, Q2 FY2025, at 2025-06-30$198.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001193125-26-338023.Report this figure190Shareholders' equity, Q3 FY2025, at 2025-09-30$189.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-13, accession 0001193125-25-280166.Report this figure183Shareholders' equity, FY2025, at 2025-12-31$183.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001193125-26-338023.Report this figure172Shareholders' equity, Q1 FY2026, at 2026-03-31$172.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001193125-26-338023.Report this figure322Shareholders' equity, Q2 FY2026, at 2026-06-30$321.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001193125-26-338023.Report this figure

Cash flow

Operating cash flow−$17.4m, Q2 FY2026
Capital expenditure$124.0k, Q2 FY2026
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$m(7.3)Operating cash flow, Q3 FY2023, three months to 2023-09-30−$7.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-06, accession 0000950170-24-122355. Derived: 9-month figure less the 6-month figure.Report this figure(6.4)Operating cash flow, Q4 FY2023, three months to 2023-12-31−$6.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-03-18, accession 0000950170-25-041194. Derived: 12-month figure less the 9-month figure.Report this figure(10.5)Operating cash flow, Q1 FY2024, three months to 2024-03-31−$10.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-08, accession 0000950170-25-067011.Report this figure(8.7)Operating cash flow, Q2 FY2024, three months to 2024-06-30−$8.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-07, accession 0000950170-25-105066. Derived: 6-month figure less the 3-month figure.Report this figure(9.6)Operating cash flow, Q3 FY2024, three months to 2024-09-30−$9.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-13, accession 0001193125-25-280166. Derived: 9-month figure less the 6-month figure.Report this figure(9.6)Operating cash flow, Q4 FY2024, three months to 2024-12-31−$9.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-17, accession 0001193125-26-110783. Derived: 12-month figure less the 9-month figure.Report this figure(13.5)Operating cash flow, Q1 FY2025, three months to 2025-03-31−$13.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-05, accession 0001193125-26-206390.Report this figure(10.1)Operating cash flow, Q2 FY2025, three months to 2025-06-30−$10.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-06, accession 0001193125-26-338023. Derived: 6-month figure less the 3-month figure.Report this figure(10.9)Operating cash flow, Q3 FY2025, three months to 2025-09-30−$10.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-13, accession 0001193125-25-280166. Derived: 9-month figure less the 6-month figure.Report this figure(7.6)Operating cash flow, Q4 FY2025, three months to 2025-12-31−$7.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-17, accession 0001193125-26-110783. Derived: 12-month figure less the 9-month figure.Report this figure(16.7)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$16.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-05, accession 0001193125-26-206390.Report this figure(17.4)Operating cash flow, Q2 FY2026, three months to 2026-06-30−$17.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-06, accession 0001193125-26-338023. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$m0.0Capital expenditure, Q3 FY2023, three months to 2023-09-30$18.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-11-06, accession 0000950170-24-122355. Derived: 9-month figure less the 6-month figure.Report this figure0.0Capital expenditure, Q4 FY2023, three months to 2023-12-31$22.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2025-03-18, accession 0000950170-25-041194. Derived: 12-month figure less the 9-month figure.Report this figurenot reportednot reported0.0Capital expenditure, Q3 FY2024, three months to 2024-09-30$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-13, accession 0001193125-25-280166. Derived: 9-month figure less the 6-month figure.Report this figure0.0Capital expenditure, Q4 FY2024, three months to 2024-12-31$7.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-17, accession 0001193125-26-110783. Derived: 12-month figure less the 9-month figure.Report this figurenot reportednot reported0.0Capital expenditure, Q3 FY2025, three months to 2025-09-30$12.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-13, accession 0001193125-25-280166. Derived: 9-month figure less the 6-month figure.Report this figure0.0Capital expenditure, Q4 FY2025, three months to 2025-12-31$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-17, accession 0001193125-26-110783. Derived: 12-month figure less the 9-month figure.Report this figure0.1Capital expenditure, Q1 FY2026, three months to 2026-03-31$102.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-05, accession 0001193125-26-206390.Report this figure0.1Capital expenditure, Q2 FY2026, three months to 2026-06-30$124.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-06, accession 0001193125-26-338023. Derived: 6-month figure less the 3-month figure.Report this figure

Shares

Diluted shares (weighted)156.60m, Q2 FY2026
Line itemUnitQ3 FY20222022-09-30Q1 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)m shares68.9Diluted shares (weighted), Q3 FY2022, three months to 2022-09-3068,898,810 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-11-09, accession 0000950170-23-062063.Report this figure98.6Diluted shares (weighted), Q1 FY2023, three months to 2023-03-3198,610,671 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-05-07, accession 0000950170-24-054489.Report this figure98.7Diluted shares (weighted), Q2 FY2023, three months to 2023-06-3098,698,579 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-08, accession 0000950170-24-093983.Report this figure99.3Diluted shares (weighted), Q3 FY2023, three months to 2023-09-3099,325,540 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-06, accession 0000950170-24-122355.Report this figure99.5Diluted shares (weighted), Q1 FY2024, three months to 2024-03-3199,517,212 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-08, accession 0000950170-25-067011.Report this figure101Diluted shares (weighted), Q2 FY2024, three months to 2024-06-30101,041,573 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-07, accession 0000950170-25-105066.Report this figure101Diluted shares (weighted), Q3 FY2024, three months to 2024-09-30101,282,228 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-13, accession 0001193125-25-280166.Report this figure118Diluted shares (weighted), Q1 FY2025, three months to 2025-03-31117,610,750 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-05, accession 0001193125-26-206390.Report this figure130Diluted shares (weighted), Q2 FY2025, three months to 2025-06-30130,350,391 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-06, accession 0001193125-26-338023.Report this figure145Diluted shares (weighted), Q3 FY2025, three months to 2025-09-30145,104,986 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-13, accession 0001193125-25-280166.Report this figure146Diluted shares (weighted), Q1 FY2026, three months to 2026-03-31145,592,901 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-05, accession 0001193125-26-206390.Report this figure157Diluted shares (weighted), Q2 FY2026, three months to 2026-06-30156,602,158 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-06, accession 0001193125-26-338023.Report this figure

Shares outstanding: 142.48mShares outstanding, period not labelled, at 2026-07-31142,475,841 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-06, accession 0001193125-26-338023.Report this figure at Jul 31, 2026, from the cover of the 10-Q filed Aug 6, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:43 ET. Listed shows no prices and gives no investment advice.